{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:24:27Z","timestamp":1794007467539,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cardfail.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T01:21:22Z","timestamp":1627176082000},"page":"247-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-5855","authenticated-orcid":false,"given":"MOHAMED","family":"ELWAZIR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MEGAN L.","family":"KRAUSE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN P.","family":"BOIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GEORGIOS","family":"CHRISTOPOULOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AYSE T.","family":"KENDI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JR. LESLIE T.","family":"COOPER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAYAN","family":"JOUNI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3256-3660","authenticated-orcid":false,"given":"OMAR F.","family":"ABOUEZZEDDINE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-8712","authenticated-orcid":false,"given":"PANITHAYA","family":"CHAREONTHAITAWEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MOHAMED","family":"ABDELSHAFEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHREYASEE","family":"AMIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2021.07.008_bib0001","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0002","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"Hamzeh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0003","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/kev309","article-title":"Successful use of rituximab in refractory cardiac sarcoidosis","volume":"55","author":"Krause","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0004","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/09273948.2012.762982","article-title":"Successful treatment of ocular sarcoidosis with rituximab","volume":"21","author":"Beccastrini","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jbspin.2008.01.025","article-title":"S, Rituximab as a treatment alternative in sarcoidosis","volume":"75","author":"Belkhou","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0006","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/WNL.0b013e3181ec7ff9","article-title":"A case of neurosarcoidosis successfully treated with rituximab","volume":"75","author":"Bomprezzi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy CMA"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0008","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1016\/j.jbspin.2009.11.005","article-title":"Relapse of severe sarcoidosis with an uncommon peritoneal location after TNF\u03b1 blockade. Efficacy of rituximab, report of a single case","volume":"77","author":"Dasilva","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0009","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Anna Rheum Dis"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0010","article-title":"Steroid refractory autoimmune haemolytic anaemia secondary to sarcoidosis successfully treated with rituximab and mycophenolate mofetil","author":"Green","year":"2016","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0011","first-page":"1613","article-title":"Rituximab for refractory granulomatous eye disease","volume":"6","author":"Lower","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0012","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12883-014-0237-5","article-title":"Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept","volume":"14","author":"Marques","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0013","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jocn.2012.09.030","article-title":"Sarcoidosis associated with neuromyelitis optica","volume":"20","author":"Sawaya","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0014","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418805732","article-title":"Successful therapy with rituximab in three patients with probable neurosarcoidosis","volume":"11","author":"Zella","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0016","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0017","first-page":"661","article-title":"Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: the effect of a structured patient preparation protocol","volume":"17","author":"Christopoulos","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0018","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC Expert Consensus Document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0019","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.amjcard.2015.12.033","article-title":"Effect of discontinuation of prednisolone therapy on risk of cardiac mortality associated with worsening left ventricular dysfunction in cardiac sarcoidosis","volume":"117","author":"Nagai","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0021","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"issue":"Suppl 10","key":"10.1016\/j.cardfail.2021.07.008_bib0022","article-title":"Successful treatment of cardiac sarcoidosis with biologic and immunosuppressive combination therapy [abstract]","volume":"67","author":"Estephan","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0023","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cardfail.2021.07.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2019.11.004","article-title":"TNF-alpha inhibition for the treatment of cardiac sarcoidosis","volume":"50","author":"Baker","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.cardfail.2021.07.008_bib0025","first-page":"124","article-title":"Infliximab for refractory cardiac sarcoidosis","author":"Harper","year":"2019","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.cardfail.2021.07.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0027","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2020.08.013","article-title":"Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience","volume":"27","author":"Gilotra","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0028","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1540-9740.2005.04502.x","article-title":"TNF-alpha inhibitors and congestive heart failure","volume":"4","author":"Behnam","year":"2005","journal-title":"Skinmed"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0029","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0030","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0031","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0032","doi-asserted-by":"crossref","first-page":"e43588","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0033","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/ced.12793","article-title":"Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab-induced reaction further supporting B-cell contribution to sarcoidosis pathogenesis?","volume":"41","author":"Galimberti","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0034","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-2600(15)00199-X","article-title":"New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches","volume":"3","author":"Baughman","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.110.952184","article-title":"Images in cardiovascular medicine: imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case","volume":"122","author":"Koiwa","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0036","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0037","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2967\/jnumed.118.221879","article-title":"Reply: role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring: addition to the expert consensus","volume":"60","author":"Chareonthaitawee","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0038","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-1275","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","volume":"79","author":"Nagai","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0039","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0040","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2967\/jnumed.110.076232","article-title":"Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques","volume":"51","author":"Gotthardt","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cardfail.2021.07.008_bib0041","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1378\/chest.11-0263","article-title":"Management of cardiac sarcoidosis in the United States: a Delphi study","volume":"141","author":"Hamzeh","year":"2012","journal-title":"Chest"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421002980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421002980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:45:54Z","timestamp":1761029154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916421002980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1071916421002980"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.008","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}